BEIJING (Reuters) – China National Biotec Group (CNBG) has administered more than 4 million COVID-19 vaccine doses as of Jan. 4 via China’s emergency use program, the company said late on Thursday.
( read original story …)
The China News
BEIJING (Reuters) – China National Biotec Group (CNBG) has administered more than 4 million COVID-19 vaccine doses as of Jan. 4 via China’s emergency use program, the company said late on Thursday.
( read original story …)